Patient with metastatic renal cell carcinoma treated successfully with pazopanib for four years.
Journal Title: OncoReview - Year 2015, Vol 5, Issue 3
Abstract
We present a case of a patient with metastatic renal cell carcinoma who was treated with pazopanib in the first-line treatment. Although nephrectomy was not performed, there was a positive reaction to the therapy with multi targeted tyrosine kinase inhibitor. After 18 months of the palliative treatment, the cancerous kidney was surgically removed and pazopanib was restarted with the effect of further disease remission. The development of hypertension, complete hair discoloration and isolated hyperbilirubinemia occurred, and there was occasionally hypokalaemia in laboratory findings within 48 months of therapy. No serious adverse events were reported.
Authors and Affiliations
Agnieszka Słowik, Joanna Streb, Robert Chrzan, Krzysztof Krzemieniecki
Keywords
Related Articles
- EP ID EP78720
- DOI 10.5604/20828691.1171780
- Views 223
- Downloads 0
Zasady postępowania diagnostyczno-terapeutycznego u chorych na nowotwory podścieliskowe przewodu pokarmowego (GIST) w 2010 roku
Nowotwory podścieliskowe przewodu pokarmowego (ang. gastrointestinal stromal tumors, GIST) są najczęstszymi nowotworami pochodzenia mezenchymalnego w obrębie przewodu pokarmowego. Nowotwory te, dzięki postępom w diagnost...
Chemotherapy in gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN)
Approximately two-thirds of malignant GEP-NENs are metastatic at discovery. Chemotherapy with platinum and etoposide is a standard therapy for poorly differentiated GEP-NEC. For well-differentiated pancreatic GEP-NEN ass...
Kontrolowane placebo, z podwójnie ślepą próbą, prospektywne, randomizowane badanie skuteczności oktreotudu LAR w kontroli guza u chorych na guzy neuroendokrynne środkowej części prajelita z przerzutami: raport grupy badawczej PROMID
Wstęp: Analogi somatostatyny są wskazane w opanowywaniu objawów u chorych na żołądkowo-jelitowo-trzustkowe guzy neuroendokrynne (NETs). Zdolność analogów somatostatyny do kontrolowania wzrostu wysoko zróżnicowanych NETs...
IgM multiple myeloma: diagnostic difficulties and results of bortezomib treatment – case report
The IgM paraprotein secretion is most frequently associated with Waldenström’s macroglobulinemia. In very rare cases it may also occur in multiple myeloma. The diagnostic and therapeutic process of a 84 year old male suf...
Safety and efficacy of liposomal doxorubicin in a patient treated for metastatic breast cancer
Breast cancer is the most common malignancy among women in Poland and all over the world. Despite the development of modern therapies, cytostatics still play one of the main roles in treatment of this disease. Classic an...